Forever Young Pharmacy
Finnrick has tested 26 samples from Forever Young Pharmacy across 5 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Semaglutide | 5 | 17 Dec 2024 | 19 Feb 2025 | |||||
| BPC-157 | 5 | 17 Dec 2024 | 19 Feb 2025 | |||||
| Tirzepatide | 3 | 2 Apr 2025 | 2 Apr 2025 | |||||
| CJC-1295 | 5 | 17 Dec 2024 | 21 Feb 2025 | |||||
| Retatrutide | 8 | 17 Dec 2024 | 31 Mar 2025 | |||||
The Forever Young Pharmacy samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Forever Young Pharmacy tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Variant | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 2 Apr 2025 | Tirzepatide | View | 15mg | (no batch claim) | 15.5mg | +3.3% | 98.82% | (no batch ID) | White Label / Silver Crimp / Blue Cap | Lab C | Public | ||
| 2 Apr 2025 | Tirzepatide | View | 15mg | (no batch claim) | 13.69mg | -8.7% | 99.92% | (no batch ID) | White Label / Silver Crimp / Purple Cap | Lab C | Public | ||
| 2 Apr 2025 | Tirzepatide | View | 30mg | (no batch claim) | 29.04mg | -3.2% | 99.95% | (no batch ID) | White Label / Silver Crimp / Light Green Cap | Lab C | Public | ||
| 31 Mar 2025 | Retatrutide | View | 10mg | (no batch claim) | 11.06mg | +10.6% | 98.29% | (no batch ID) | White Label / Green Crimp / Clear Cap | Lab C | Public | ||
| 28 Mar 2025 | Retatrutide | View | 20mg | (no batch claim) | 22.28mg | +11.4% | 98.78% | (no batch ID) | White Label / Silver Crimp / Red Cap | Lab C | Public | ||
| 28 Mar 2025 | Retatrutide | View | 10mg | (no batch claim) | 11.79mg | +17.9% | 89.66% | (no batch ID) | White Label / Purple Crimp / Clear Cap | Lab C | Public | ||
| 21 Feb 2025 | CJC-1295 | View | No DAC | 5mg | 5.5mg | 6.17mg | +12.0% | 98.49% | 22470 | White Label / Silver Crimp / Clear Blue Cap | Lab B | Finnrick | |
Corrections
- 6 Apr 2025: Retatrutide
- Lab A test 14 Feb 2025: updated compound identification, removed purity and quantity values. Error in analysis by lab, compound was incorrectly identified as Retatrutide. Lab issued an updated test certificate.
About Forever Young Pharmacy Test Results From Finnrick
Forever Young Pharmacy is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 5 products and 26 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Forever Young Pharmacy Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Forever Young Pharmacy. The overall dataset includes 26 tested samples with an average score of 5.8/10 across all products.
Across 26 identity-tested samples, 85% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.6%. Approximately 91% of passing samples tested at or above 98% purity.